EUVIMEDEUVIMED entdecken
Crossref

Tumor-secreted Autocrine Motility Factor: Pro-melanogenic Activity at Low Doses and Reversal Effect at Higher Doses Combined With Glycyrrhetinic Acid

Na Young Park, Hee Sung Park, Changyul Kim, Se Gie Kim, Jihye Lee

Anticancer Research · 2026-08 · 46 (8) · 4323-4329

DOI: 10.21873/anticanres.18290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Na Young Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Food Science and Technology, Daegu Catholic University, Gyeongsan, Republic of Korea. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid, Melanins, Melanoma, Experimental.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Skin darkening can result from various factors, with prolonged sun exposure being a primary cause. α-Melanocyte-stimulating hormone (α-MSH) plays a crucial role in stimulating melanin production. However, our understanding of hyperpigmentation in individuals with cancer or rheumatoid arthritis (RA) remains limited. This study investigated the effect of autocrine motility factor (AMF) on hyperpigmentation. MATERIALS AND METHODS: The effect of AMF on melanogenesis was examined in B16F10 mouse melanoma cells through growth assays, quantitative PCR, western blot analysis, and tyrosinase activity assays. Effects of glycyrrhetinic acid (GA) alone and in combination with AMF were also evaluated. RESULTS: At lower doses, AMF promoted melanogenesis by upregulating melanogenesis-related genes, with efficacy comparable to that of α-MSH. Higher doses of AMF significantly suppressed melanogenesis, accompanied by decreased B16F10 cell growth. GA inhibited melanin production, and its co-administration with AMF showed synergy. Additionally, GA counteracted the AMF-induced increase in melanin production. CONCLUSION: AMF may play a role in pathological condition-related skin darkening, and GA represents a potential agent for regulating hyperpigmentation when combined with AMF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycyrrhetinic AcidMelaninsMelanoma, ExperimentalAnimalsMiceMelanogenesisCell Line, TumorCell ProliferationDose-Response Relationship, Drugalpha-MSHHyperpigmentation

Stichwörter der Autor:innen

Autocrine motility factorB16F10 mouse melanoma cellsglycyrrhetinic acidhyperpigmentationmelanogenesis

Substanzen

Glycyrrhetinic AcidMelaninsalpha-MSH

Autor:innen und Institutionen

  • Department of Health Food Science and Technology, Daegu Catholic University, Gyeongsan, Republic of Korea.
  • Department of Health Management, Daegu Catholic University, Gyeongsan, Republic of Korea.
  • Department of Cosmetic Science, Kyungsung University, Busan, Republic of Korea; sgkim@ks.ac.kr.
  • Industry Academic Cooperation Foundation, Daegu Haany University, Gyeongsan, Republic of Korea jhlee86@dhu.ac.kr.

Zitieren

APA

Park, N. Y., Park, H. S., Kim, C., Kim, S. G., & Lee, J. (2026). Tumor-secreted Autocrine Motility Factor: Pro-melanogenic Activity at Low Doses and Reversal Effect at Higher Doses Combined With Glycyrrhetinic Acid. Anticancer Research, 46(8), 4323-4329. https://doi.org/10.21873/anticanres.18290

Vancouver

Park NY, Park HS, Kim C, Kim SG, Lee J. Tumor-secreted Autocrine Motility Factor: Pro-melanogenic Activity at Low Doses and Reversal Effect at Higher Doses Combined With Glycyrrhetinic Acid. Anticancer Research. 2026;46(8):4323-4329. doi:10.21873/anticanres.18290

BibTeX
@article{Park2026,
  author = {Park, Na Young and Park, Hee Sung and Kim, Changyul and Kim, Se Gie and Lee, Jihye},
  title = {Tumor-secreted Autocrine Motility Factor: Pro-melanogenic Activity at Low Doses and Reversal Effect at Higher Doses Combined With Glycyrrhetinic Acid},
  journal = {Anticancer Research},
  year = {2026},
  volume = {46},
  number = {8},
  pages = {4323--4329},
  doi = {10.21873/anticanres.18290}
}
Kostenlos starten →